Table 3 Kaplan-Meier event rates through 30-day follow-up, use of intravenous diuretics and length of stays
Total (n = 199) | NT-proBNP ≤ 450 pg/ml (n = 129) | NT-proBNP > 450 pg/ml (n = 70) | p | |
|---|---|---|---|---|
Composite Morbidity Endpoint - no. (%) | 90 (45.9) | 41 (32.4) | 49 (70.7) | < 0.001 |
Any rehospitalisation - no. (%) | 23 (11.9) | 11 (8.8) | 12 (17.7) | 0.056 |
Cardiac rehospitalisation - no. (%) | 3 (1.6) | 0 (0.0) | 3 (4.4) | 0.018 |
Acute decompensated heart failure - no. (%) | 19 (9.7) | 5 (4.0) | 14 (20.1) | < 0.001 |
Acute kidney injury - no. (%) | 36 (19.4) | 10 (8.3) | 26 (39.8) | < 0.001 |
Stage 1 - no. (%) | 26 (14.4) | 8 (6.7) | 18 (29.8) | < 0.001 |
Stage 2 - no. (%) | 5 (2.8) | 1 (0.8) | 4 (6.9) | 0.026 |
Stage 3 - no. (%) | 5 (2.8) | 1 (0.9) | 4 (6.3) | 0.025 |
Any bacterial infection - no. (%) | 63 (32.1) | 31 (24.4) | 32 (46.3) | 0.001 |
Pneumonia - no. (%) | 8 (4.6) | 2 (1.6) | 6 (10.9) | 0.011 |
Abdominal infection - no. (%) | 13 (7.1) | 10 (8.1) | 3 (4.9) | 0.433 |
Urinary tract infection - no. (%) | 13 (7.8) | 6 (5.4) | 7 (13.0) | 0.089 |
Wound infection - no. (%) | 8 (4.9) | 5 (4.8) | 3 (4.5) | 0.717 |
Other - no. (%) | 21 (12.4) | 8 (7.1) | 13 (22.9) | 0.003 |
Further morbidity measures | ||||
Myocardial infarction - no. (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.0 |
Wound healing disturbance - no. (%) | 10 (5.2) | 5 (4.0) | 5 (7.4) | 0.312 |
Mortality - no. (%) | 4 (2.0) | 1 (0.8) | 3 (4.3) | 0.094 |
Cardiac - no. (%) | 1 (0.5) | 0 (0.0) | 1 (1.5) | 0.169 |
Postoperative diuretics | ||||
Postoperative diuretics [IQR] - mg/d* | 0.0 [0.0–1.4] | 0.0 [0.0–0.0] | 0.10 [0.0–5.9] | < 0.001 |
Length of stays | ||||
ICU stay [IQR] - d | 0.9 [0.0–1.3] | 0.8 [0–1.1] | 1.1 [0.8–3.5] | < 0.001 |
Hospital stay [IQR] - d | 10 [6-17] | 0.8 [6–13] | 15 [8–21] | < 0.001 |